Need help?

Pharmaceuticals Company for Sale in Riga, Latvia

EU-licensed pharmaceutical wholesale platform with GDP infrastructure, cold-chain capability, and regulatory readiness seeking acquisition.

Established 1-5 year(s)
Employees 2 - 5
Legal Entity Limited Liability Company (LLC)
Reported Sales USD 30 - 40 thousand
Run Rate Sales Nil
EBITDA Margin Nil
Industries Pharmaceuticals
Locations  Riga
Local Time 12:21 PM Europe / Riga
Listed By Management Member
Status Active
Overall Rating
Full Sale
Asking Price: USD 390 thousand (Native Currency: EUR 350,000)
Reason: The shareholders have decided to pursue other business interests. The company is fully established a... View More
Includes physical assets worth USD 15.7 thousand
Name, Phone, Email
Available after connect
Business Name
Not disclosed
User Verification
Documents
Teaser
Business Overview
• EU-licensed pharmaceutical wholesale and distribution company with established GDP-compliant infrastructure and specialized pharmaceutical distribution capabilities.
• The company is currently non-operational, having stopped commercial operations a few months ago.
• Provides an established licensed platform for pharmaceutical wholesale and distribution within the European Union.
• The infrastructure includes an operational pharmaceutical warehouse with cold-chain capability and specialized storage for controlled narcotic and psychotropic medicines within the scope of its authorizations.
• The facility includes validated warehouse-management processes and an established regulatory and compliance framework designed to support pharmaceutical storage and distribution.
• The company has intentionally maintained limited commercial activity while preserving its regulatory and operational infrastructure and readiness.
• Historical revenue and EBITDA are therefore not representative of the business's underlying commercial potential.
• The opportunity is primarily the acquisition of an established, licensed pharmaceutical platform that can provide a buyer with an existing base for developing or expanding pharmaceutical operations in the EU.
• Client and customer information can be provided to qualified parties after signing an NDA.
• The company holds the required business registration and regulatory authorizations for its pharmaceutical wholesale activities.
Products & Services Overview
The company provides licensed pharmaceutical wholesale and distribution infrastructure, including cold-chain and controlled-medicine storage capabilities, for pharmaceutical companies seeking an established EU operational platform. Client information will be shared after signing an NDA.
Assets Overview
Tangible assets.
• Pharmaceutical warehouse infrastructure: Warehouse premises and physical infrastructure used for pharmaceutical storage and distribution.
• Company-owned warehouse equipment: Storage, handling, and other equipment supporting pharmaceutical operations.
• Cold-chain infrastructure: Refrigeration and temperature-controlled storage equipment.
• Controlled-medicine storage infrastructure: Specialized physical storage facilities and security equipment for authorized narcotic and psychotropic medicines.
• Other operational assets: Office equipment, fixtures, and other physical assets supporting warehouse and distribution operations.

Intangible assets.
• Existing EU pharmaceutical wholesale regulatory authorizations and licenses.
• GDP-compliant operational framework and established compliance processes.
• Validated warehouse-management processes and systems.
• Quality management and compliance documentation.
• Established pharmaceutical distribution procedures and operational know-how.
• Company website and digital assets.
• Established regulatory and operational readiness for pharmaceutical wholesale and distribution within the EU.
Facilities Overview
Approx. 300 m² leased pharmaceutical warehouse and office premises in Riga, Latvia. The premises are equipped for licensed pharmaceutical wholesale operations and include controlled storage areas, cold-chain infrastructure and dedicated storage for controlled medicines. The existing lease arrangement may be continued subject to agreement with the property owner.
Capitalization Overview
The company is privately owned by two individual shareholders (50 x 50) and has historically been funded by its owners to maintain the licensed pharmaceutical infrastructure and regulatory readiness. Any outstanding shareholder financing and historical liabilities will be settled or otherwise addressed as part of the transaction, so that the agreed transaction structure is clear to the buyer.
Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
1 Buyer contacted this Business this month. Register below to connect now!
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses
    Frequently
    Asked
    Questions
    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more

    Chat with Us
    Welcome to SMERGERS